Why AI matters at this scale

UConn Health's Department of Pediatrics is a major academic research hub within a large health system, conducting critical pediatric clinical trials. With a staff size of 5,001-10,000, the organization generates and manages vast amounts of clinical and research data. At this scale, manual processes for patient recruitment, data monitoring, and protocol management become significant bottlenecks, delaying breakthroughs and increasing costs. AI offers the tools to systematically analyze this data, uncover insights hidden to human reviewers, and automate administrative burdens. For a sector where time directly impacts children's health outcomes and research costs run into the millions per trial, leveraging AI is transitioning from a competitive advantage to an operational necessity to fulfill their mission efficiently.

Concrete AI Opportunities with ROI Framing

1. AI-Driven Patient Recruitment & Matching: Pediatric trials notoriously struggle with recruitment due to smaller, protected populations. An AI system that continuously screens Electronic Health Records (EHR) against complex trial criteria can identify eligible patients in real-time. This reduces recruitment timelines from months to weeks, cutting a major cost center. For a large department running dozens of trials, this could save millions annually in reduced screen-failure costs and accelerated grant cycles, delivering a direct and substantial ROI.

2. Predictive Analytics for Patient Retention: Participant drop-out jeopardizes trial validity and investment. Machine learning models can analyze baseline data and early visit patterns to predict which children are at highest risk of non-adherence. Research coordinators can then deploy targeted support—such as reminder systems, transportation aid, or educational outreach—to improve retention. This protects the integrity of expensive, long-term studies, ensuring a return on the significant investment in each enrolled participant.

3. Automated Adverse Event (AE) Monitoring: Manually reviewing patient reports and lab data for safety signals is slow and prone to oversight. Natural Language Processing (NLP) can scan clinician notes, and anomaly detection can monitor lab trends, flagging potential AEs faster. This enhances patient safety, ensures regulatory compliance, and can prevent costly protocol violations or trial pauses. The ROI manifests in risk mitigation, reduced monitoring costs, and stronger safety profiles for new therapies.

Deployment Risks Specific to This Size Band

Implementing AI in a large, bureaucratic academic medical center presents distinct challenges. Data Silos: Despite its size, data is often fragmented across clinical EHRs, research databases, and departmental systems, requiring complex integration projects. Change Management: Rolling out new AI tools to thousands of staff—from physicians to coordinators—requires extensive training and can meet resistance to altered workflows. Regulatory Scrutiny: As part of a prominent public institution, their AI initiatives will face intense internal and external audit, requiring impeccable documentation for FDA, HIPAA, and IRB compliance. Vendor Lock-in: The scale may push them toward enterprise vendors, creating dependency and limiting flexibility. A successful strategy must include a robust data governance framework, phased pilots with clear champions, and a focus on interpretable AI models that can withstand regulatory examination.